In this study, only one patient who had not undergone TB screening and did not receive TB chemoprophylaxis was diagnosed with intestinal TB after 14 months of treatment with the IL-17 inhibitor, ixekizumab [11]. This evidence concerns the gene IL17A and tuberculosis.